Trials / Completed
CompletedNCT04480398
Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients
A Retrospective Study on Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- Aarogyam UK · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Coronavirus disease 2019 (Covid-19) has been declared global emergency with immediate safety, preventative and curative measures to control the spread of virus. Confirmed cases are treated with clinical management as they are diagnosed but so far, there is no effective treatment or vaccine yet for Covid-19. With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear. Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Guduchi Ghan Vati | Guduchi Ghan Vati is an Ayuvedic classical preparation which is prepared from aqueous of extract of Tinospora cordifolia. |
Timeline
- Start date
- 2020-05-12
- Primary completion
- 2020-06-15
- Completion
- 2020-07-03
- First posted
- 2020-07-21
- Last updated
- 2020-07-22
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04480398. Inclusion in this directory is not an endorsement.